RLAY RELAY THERAPEUTICS INC Product Launches 8-K Filing 2023 - Product Launch Relay Therapeutics, Inc. announced the initial clinical data for RLY-2608, an investigational cancer inhibitor, presented at the AACR Annual Meeting 2023.Get access to all SEC 8-K filings of the RELAY THERAPEUTICS INC